BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11284408)

  • 1. [What is happening within cancer drug therapy? The Danish Society of Medical Oncology].
    Dansk Selskab for Medicinsk Onkologi's bestyrelse (DMO)
    Ugeskr Laeger; 2001 Mar; 163(12):1708. PubMed ID: 11284408
    [No Abstract]   [Full Text] [Related]  

  • 2. [The current potentials and outlook for drug therapy in oncology].
    Gershanovich ML; Borisov VI; Sidorenko IuS; Tiuliandin SA; Gorbunova VA
    Vopr Onkol; 1995; 41(2):116-24. PubMed ID: 7483406
    [No Abstract]   [Full Text] [Related]  

  • 3. X chemotherapy, myth and realities.
    Thomas M; Pavithran K
    J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Future cancer care challenges the health care].
    Olofsson S
    Lakartidningen; 2010 Apr 21-27; 107(16):1065. PubMed ID: 20476702
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in medical oncology].
    Shi YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current trends in clinical chemotherapy of tumors].
    Garan AM
    Vopr Onkol; 1983; 29(1):93-8. PubMed ID: 6823764
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in drug development: off-label drug utilization in oncology.
    de Souza JA
    Clin Adv Hematol Oncol; 2011 Jun; 9(6):473-5. PubMed ID: 21841748
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic drug monitoring in oncology: does it have a future?
    McMahon G; O'Connor R
    Bioanalysis; 2009 Jun; 1(3):507-11. PubMed ID: 21083145
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer and leukemia group B breast committee: decades of progress and plans for the future.
    Hudis CA; Winer EP
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development trends for monoclonal antibody cancer therapeutics.
    Reichert JM; Valge-Archer VE
    Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Great risk of future problems for Swedish cancer care].
    Bergh J; Wilking N
    Lakartidningen; 2010 Oct 6-12; 107(40):2376-7. PubMed ID: 21140568
    [No Abstract]   [Full Text] [Related]  

  • 12. [New therapeutic strategies in oncology].
    Bohuon C
    Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of cancer care quality study lead to cautious optimism, caveats.
    Christensen D
    J Natl Cancer Inst; 2004 Aug; 96(15):1124-5. PubMed ID: 15292381
    [No Abstract]   [Full Text] [Related]  

  • 14. 25 years of oncology.
    Spittle MF
    Br J Hosp Med; 1991 Oct; 46(4):249, 251. PubMed ID: 1954491
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncologists have lost a battle against cancer; biomedicine has not lost the war.
    Mathé G
    Biomed Pharmacother; 1986; 40(10):370-1. PubMed ID: 3580504
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing patterns of surgical oncologists: are we surgeons, oncologists, or both? Results of a society of surgical oncology survey.
    Balch CM
    Ann Surg Oncol; 2007 Oct; 14(10):2685-6. PubMed ID: 17786520
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cancer chemotherapy; past, present and future--from the aspect of fundamental studies].
    Tukagoshi S
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1398-403. PubMed ID: 14584271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer care expands to include genetic testing.
    Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):4-5. PubMed ID: 19408409
    [No Abstract]   [Full Text] [Related]  

  • 19. American society of clinical oncology--41st annual meeting. Immunology.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):528-30. PubMed ID: 15973554
    [No Abstract]   [Full Text] [Related]  

  • 20. Cracking the mild, difficult and fiendish codes within and downstream of the EGFR to link diagnostics and therapeutics.
    Waterfield M
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):1-6. PubMed ID: 17212578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.